Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
System Biosciences is a leading provider of innovative products and services that accelerate molecular and cell biology research. The company pioneered commercial exosome isolation kits in 2009 and was among the first to market with CRISPR/Cas9 vectors. Its offerings support thousands of published studies worldwide across diverse fields such as exosome biology, gene delivery/expression analysis, liquid biopsy biomarker discovery, imaging/reporting vectors for live-cell analysis, RNAi screening platforms for functional genomics studies[1][2][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on System Biosciences.